116 related articles for article (PubMed ID: 16079485)
1. In vitro antifungal activity of ZJ-522, a new triazole restructured from fluconazole and butenafine, against clinically important fungi in comparison with fluconazole and butenafine.
Gao PH; Cao YB; Xu Z; Zhang JD; Zhang WN; Wang Y; Gu J; Cao YY; Li RY; Jia XM; Jiang YY
Biol Pharm Bull; 2005 Aug; 28(8):1414-7. PubMed ID: 16079485
[TBL] [Abstract][Full Text] [Related]
2. [Activity of butenafine against ocular pathogenic filamentous fungi in vitro].
Xu Y; Pang GR; Zhao DQ; Gao CW; Zhou LT; Sun ST; Wang BL; Chen ZJ
Zhonghua Yan Ke Za Zhi; 2010 Jan; 46(1):38-42. PubMed ID: 20388321
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of in vitro activity of ciclopirox olamine, butenafine HCl and econazole nitrate against dermatophytes, yeasts and bacteria.
Kokjohn K; Bradley M; Griffiths B; Ghannoum M
Int J Dermatol; 2003 Sep; 42 Suppl 1():11-7. PubMed ID: 12895182
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
Gupta AK; Kohli Y; Batra R
Med Mycol; 2005 Mar; 43(2):179-85. PubMed ID: 15832561
[TBL] [Abstract][Full Text] [Related]
5. [The effect of propyl gallate on the activity of various antifungal drugs against filamentous fungi in vitro].
Xu Y; Pang GR; Lü XF; Chen ZJ; Sun ST; Song JZ
Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):309-12. PubMed ID: 16762206
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of a new oral triazole, BMS-207147 (ER-30346).
Fung-Tomc JC; Huczko E; Minassian B; Bonner DP
Antimicrob Agents Chemother; 1998 Feb; 42(2):313-8. PubMed ID: 9527778
[TBL] [Abstract][Full Text] [Related]
7. Current advances of triazole alcohols derived from fluconazole: Design, in vitro and in silico studies.
Emami S; Ghobadi E; Saednia S; Hashemi SM
Eur J Med Chem; 2019 May; 170():173-194. PubMed ID: 30897396
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
[TBL] [Abstract][Full Text] [Related]
9. [Synthesis and antifungal activity of butenafine hydrochloride (KP-363), a new benzylamine antifungal agent].
Maeda T; Takase M; Ishibashi A; Yamamoto T; Sasaki K; Arika T; Yokoo M; Amemiya K
Yakugaku Zasshi; 1991 Feb; 111(2):126-37. PubMed ID: 2056447
[TBL] [Abstract][Full Text] [Related]
10. In vitro antifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole.
Rudramurthy SM; Jatana M; Singh R; Chakrabarti A
Mycoses; 2013 Jan; 56(1):39-46. PubMed ID: 22519679
[TBL] [Abstract][Full Text] [Related]
11. Novel triazole alcohol antifungals derived from fluconazole: design, synthesis, and biological activity.
Hashemi SM; Badali H; Faramarzi MA; Samadi N; Afsarian MH; Irannejad H; Emami S
Mol Divers; 2015 Feb; 19(1):15-27. PubMed ID: 25182365
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of the in vitro activity of terbinafine.
Jessup CJ; Ryder NS; Ghannoum MA
Med Mycol; 2000 Apr; 38(2):155-9. PubMed ID: 10817232
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, and Biological Activity of New Triazole and Nitro-Triazole Derivatives as Antifungal Agents.
Sadeghpour H; Khabnadideh S; Zomorodian K; Pakshir K; Hoseinpour K; Javid N; Faghih-Mirzaei E; Rezaei Z
Molecules; 2017 Jul; 22(7):. PubMed ID: 28698522
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of voriconazole against yeasts, moulds and dermatophytes in comparison with fluconazole, amphotericin B and griseofulvin.
Wildfeuer A; Seidl HP; Paule I; Haberreiter A
Arzneimittelforschung; 1997 Nov; 47(11):1257-63. PubMed ID: 9428984
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antifungal activity of the novel triazole derivatives containing 1,2,3-triazole fragment.
Yu S; Wang N; Chai X; Wang B; Cui H; Zhao Q; Zou Y; Sun Q; Meng Q; Wu Q
Arch Pharm Res; 2013 Oct; 36(10):1215-22. PubMed ID: 23640383
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, molecular docking, and biological evaluation of novel triazole derivatives as antifungal agents.
Guan Z; Chai X; Yu S; Hu H; Jiang Y; Meng Q; Wu Q
Chem Biol Drug Des; 2010 Dec; 76(6):496-504. PubMed ID: 20973917
[TBL] [Abstract][Full Text] [Related]
18. [Synthesis and antifungal activity of novel triazole antifungal agents].
Sheng CQ; Zhu J; Zhang WN; Song YL; Zhang M; Ji HT; Yu JX; Yao JZ; Yang S; Miao ZY
Yao Xue Xue Bao; 2004 Dec; 39(12):984-9. PubMed ID: 15813026
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of fluconazole analogs with triazole-modified scaffold as potent antifungal agents.
Hashemi SM; Badali H; Irannejad H; Shokrzadeh M; Emami S
Bioorg Med Chem; 2015 Apr; 23(7):1481-91. PubMed ID: 25740636
[TBL] [Abstract][Full Text] [Related]
20. [Colorimetric broth microdilution for antifungal susceptibility testing].
Yamane N; Tosaka M; Okazawa Y
Rinsho Byori; 1996 Jan; 44(1):67-75. PubMed ID: 8691643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
